Literature DB >> 28259650

Can we make cannabis safer?

Amir Englund1, Tom P Freeman2, Robin M Murray3, Philip McGuire3.   

Abstract

Cannabis use and related problems are on the rise globally alongside an increase in the potency of cannabis sold on both black and legal markets. Additionally, there has been a shift towards abandoning prohibition for a less punitive and more permissive legal stance on cannabis, such as decriminalisation and legalisation. It is therefore crucial that we explore new and innovative ways to reduce harm. Research has found cannabis with high concentrations of its main active ingredient, δ-9-tetrahydrocannabinol (THC), to be more harmful (in terms of causing the main risks associated with cannabis use, such as addiction, psychosis, and cognitive impairment) than cannabis with lower concentrations of THC. By contrast, cannabidiol, which is a non-intoxicating and potentially therapeutic component of cannabis, has been found to reduce the negative effects of cannabis use. Here, we briefly review findings from studies investigating various types of cannabis and discuss how future research can help to better understand and reduce the risks of cannabis use.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28259650     DOI: 10.1016/S2215-0366(17)30075-5

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


  35 in total

Review 1.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

2.  Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.

Authors:  Benedikt Fischer; Cayley Russell; Jürgen Rehm; Pamela Leece
Journal:  J Public Health (Oxf)       Date:  2019-06-01       Impact factor: 2.341

Review 3.  Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

Authors:  John A Lawson; Ingrid E Scheffer
Journal:  Br J Clin Pharmacol       Date:  2018-09-05       Impact factor: 4.335

4.  Commentary on "The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis".

Authors:  Philip McGuire; Amir Englund; Sagnik Bhattacharyya
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

5.  Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state.

Authors:  Rosanna Smart; Jonathan P Caulkins; Beau Kilmer; Steven Davenport; Greg Midgette
Journal:  Addiction       Date:  2017-07-04       Impact factor: 6.526

6.  Feasibility and effects of galantamine on cognition in humans with cannabis use disorder.

Authors:  Dawn E Sugarman; Joao P De Aquino; James Poling; Mehmet Sofuoglu
Journal:  Pharmacol Biochem Behav       Date:  2019-05-10       Impact factor: 3.533

7.  Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws.

Authors:  Deborah S Hasin; Jacob Borodovsky; Dvora Shmulewitz; Claire Walsh; Ofir Livne; Cara A Struble; Efrat Aharonovich; David S Fink; Alan Budney
Journal:  Drug Alcohol Depend       Date:  2021-10-29       Impact factor: 4.492

8.  Concerns, beliefs and attitudes of pharmacists and pharmacy students on cannabis use in Canada.

Authors:  Régis Vaillancourt; Rahim Dhalla; Piotr Merks; Taylor Lougheed; Gary Goldfield; Holly Mansell; Jameason Cameron
Journal:  Can Pharm J (Ott)       Date:  2022-06-15

9.  Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample.

Authors:  Sinikka L Kvamme; Michael M Pedersen; Kristine Rømer Thomsen; Birgitte Thylstrup
Journal:  Harm Reduct J       Date:  2021-07-10

10.  Adverse effects of heavy cannabis use: even plants can harm the brain.

Authors:  Lucia Sideli; Giulia Trotta; Edoardo Spinazzola; Caterina La Cascia; Marta Di Forti
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.